Hideomi Watanabe

FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 Lesions

Jun Aoki, Hideomi Watanabe, Tetsuya Shinozaki et al. · Radiology · 2001 · 318 citations

Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.

Yasufumi Niinaka, S Paku, Akihiro Haga et al. · PubMed · 1998 · 141 citations

Immunology, Pathology, Tumor Cells +17

Identification of B16-F1 melanoma autocrine motility-like factor receptor.

Ivan R. Nabi, Hideomi Watanabe, Avraham Raz · PubMed · 1990 · 134 citations

Immunology, Cytoskeleton, Pertussis Toxin +17

The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein¹

Kimihiro Shimizu, Masachika Tani, Hideomi Watanabe et al. · FEBS Letters · 1999 · 119 citations · Full text

Schwannoma of the extremities: the role of PET in preoperative planning

Adel Refaat Ahmed, Hideomi Watanabe, Jun Aoki et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 112 citations

Neuro-oncology, Surgical Pathology, Preoperative Planning +5